A Clinical Observational Study Evaluating the Efficacy of Cerave Neuroceramide Intensive Repair Body Lotion .

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorChinaNorm

About this trial

This study is a single-center observational clinical study aimed at evaluating the impact of Cerave Neuroceramide Moisturizing Repair Body Lotion on the quality of life, improvement in skin condition, and satisfaction with the product experience among individuals with moderate to severe dry skin associated with aging. The study plans to recruit approximately 210 male or female participants aged 55 years or older with moderate to severe skin dryness in the affected areas (accounting for a dropout rate and protocol violation rate of no more than 5%), and will screen participants based on inclusion and exclusion criteria to ensure that at least 200 participants complete the study. Participants entering this study will be categorized based on ODS and NRS scores into: moderate or severe skin dryness (moderate-grade 2, severe-grade 3), with the sample size ratio between moderate and severe groups maintained at 1:1. This study will last for 4 weeks and include 2 visits. Visits will be conducted at baseline (T0) and week 4 (T4w). The window period for the week 4 (T4w) visit is ±2 days. This study does not involve randomization. All study participants will use Cerave Neuroceramide Moisturizing Repair Body Lotion on areas of skin dryness.

Eligibility criteria

Qualifiers

Individuals with moderate to severe skin dryness as assessed by a clinician (ODS score of 2 or 3)

Individuals with moderate to severe self-reported skin itching as assessed by a clinician (NRS ≥ 1)

Individuals aged 55 years and older

History of atopic dermatitis;

Disqualifiers

Individuals with a history of allergy, allergic reaction, or hypersensitivity to any component of the study product (Cerave Neuroceramide Moisturizing Repair Body Lotion);

Individuals with a history of allergic contact dermatitis secondary to the use of moisturizing products;

Individuals with any clinical manifestations or other conditions at the treatment site that the physician deems may affect the evaluation or results of the study product;

Individuals who are unable or unwilling to attend all study visits and adhere to the treatment regimen;

Trial design

Treatments tested in this trial

  • skin care product(Cerave Neuroceramide Moisturizing Repair Body Lotion)

Treatment groups

210 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators